SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-057796
Filing Date
2024-05-10
Accepted
2024-05-10 16:05:22
Documents
1
Period of Report
2024-05-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3947
  Complete submission text file 0000950170-24-057796.txt   5520
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O REATA PHARMACEUTICALS, INC. 2801 GATEWAY DRIVE, SUITE 150 IRVING TX 75063
Business Address
Bir Dawn Carter (Reporting) CIK: 0001688712 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 24934761